Delivery Order SPE2DB22D3501-SPE2DB25FWM00
- Not listed
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $2,166.03 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) with a firm fixed price and an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,561.94 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of OxyContin ER 40 mg tablets (100-count units). This is a firm fixed-price contract with an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.20 for OxyContin ER 10 mg tablets (100-count) with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100s) with a ceiling value of $1,222.44 and an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was made without set-aside designation, demonstrating...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,591.48 and a firm fixed price contract type. The award, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,125.41 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100 count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,587.64 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) on September 5, 2025, with completion expected by September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,717.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM00Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,932.66 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count bottles) with an ultimate completion date of July 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated consistent capability to compete successfully for federal medical procurement across multiple therapeutic domains, from routine pharmaceuticals to specialty medications and medical devices. This delivery order reflects the company's ongoing role as a critical vendor within the DLA's Medical Supply Chain, supporting the Department of Defense's healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/18/25 |